Global Infanrix And Infanrix hexa Strategies 2025, Forecast To 2034
11 Mar, 2025
What Is The Current and Historic Market Size Analysis Of The Infanrix And Infanrix hexa Market?
The infanrix and infanrix hexa market has seen considerable growth due to a variety of factors.
• In recent years, the market size for infanrix and infanrix-hexa has escalated by XX (HCAGR). It is expected to increase from $XX million in 2024 to $XX million in 2025, progressing at a Compound Annual Growth Rate (CAGR) of XX%.
The growth observed in the historical period can be credited to heightened awareness regarding diseases that can be prevented by vaccines, the expansion of government immunization programs, growing awareness about poliovirus diseases, amplified global immunization initiatives, increased understanding of child healthcare, and growth of healthcare infrastructure.
What Are The Predictions for The Infanrix And Infanrix hexa Market?
The infanrix and infanrix hexa market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated growth for the Infanrix and Infanrix-hexa market is projected to see XX (FCAGR) in the upcoming years, swelling to a substantial $XX million by 2029 with a Compound Annual Growth Rate (CAGR) of XX%.
This predicted growth during the prognosis period can be attributed to several key factors such as heightened global vaccination campaigns, increased occurrence of diseases preventable by vaccines, improved healthcare accessibility in developing economies, supportive regulations and financial backing from governments, and rising consciousness about the importance of pediatric vaccination. Predominant trends expected during the forecast period involve progress in cold chain logistics, merging with digital vaccination tracking systems, innovations in vaccine formulations, advancements in vaccine delivery methodologies, and progress in combination vaccines.
What Key Factors and Trends Are Driving The Growth Infanrix And Infanrix hexa Market?
The escalating number of whooping cough instances is anticipated to propel the Infanrix and Infanrix-hexa markets' expansion. Whooping cough, also known as pertussis, is a highly infectious respiratory illness, and its prevalence signifies the recorded cases during a specific timeframe. Lower vaccination rates, changes in immunity, and an upturn in unidentified or incorrectly diagnosed instances have resulted in an increased occurrence of pertussis. This surge in pertussis instances prompts the need for Infanrix and Infanrix-hexa vaccines as they effectively avert the highly infectious disease, leading to an upswing in their adoption and consequently in the market growth. As an example, the Health Protection Surveillance Centre, an Ireland-based specialist agency that monitors communicable diseases, reported around 514 pertussis cases in Ireland in October 2024, a stark rise from the former 18 cases in 2023. Furthermore, 2022 saw 7 cases, and 2021 had 5 cases. Hence, the escalating prevalence of pertussis incidents will fuel the expansion of the Infanrix and Infanrix Hexa vaccine market.
What Are The Core Segments Of The Global Infanrix And Infanrix hexa Market?
The infanrix and infanrix-hexa market covered in this report is segmented –
1) By Patient Demographics: Infants, Children, Adolescents And Adults
2) By Clinical Indication: Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B (Hib)
3) By Distribution Channel: Hospitals, Clinics, Public Health Programs, Pharmacies
4) By Application: Primary Vaccination, Booster Doses, Combination With Other Vaccines
Who Are the Key Players In The Infanrix And Infanrix hexa Market?
Major companies operating in the infanrix and infanrix-hexa market are:
• GlaxoSmithKline plc
What Are The Regional Insights Into The Infanrix And Infanrix hexa Market?
North America was the largest region in the infanrix and infanrix-hexa market in 2024. The regions covered in the infanrix and infanrix-hexa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.